Literature DB >> 15234437

Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors.

Gian Paolo Rossi, Giuseppe Maiolino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234437     DOI: 10.1016/j.jacc.2004.04.005

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Genetic polymorphisms of TP53 and FAS promoter modulate the progression of coronary artery disease after coronary artery bypass grafting: a gender-specific view.

Authors:  A Beiras-Fernandez; M K Angele; C Koutang; P Lohse; B Reichart; P Lohse; S Eifert
Journal:  Inflamm Res       Date:  2011-02-01       Impact factor: 4.575

2.  Macrophage migration inhibitory factor polymorphism is associated with susceptibility to inflammatory coronary heart disease.

Authors:  Kangting Ji; Xiaoyan Wang; Ji Li; Qin Lu; Guoqiang Wang; Yangjing Xue; Suqin Zhang; Lu Qian; Wenwu Wu; Yongjin Zhu; Luping Wang; Lianming Liao; Jifei Tang
Journal:  Biomed Res Int       Date:  2015-03-04       Impact factor: 3.411

3.  Association of the lipoprotein lipase and Apolipoprotein C-II gene polymorphisms with risk of dyslipidemia in smokers and non-smokers male.

Authors:  Rithab Ibrahim Al-Samawi; Maha Fadil Smaism
Journal:  Indian Heart J       Date:  2021-12-15

4.  Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG.

Authors:  Sandra Eifert; Astrid Rasch; Andres Beiras-Fernandez; Georg Nollert; Bruno Reichart; Peter Lohse
Journal:  J Cardiothorac Surg       Date:  2009-08-19       Impact factor: 1.637

5.  DNA polymorphisms of the lipoprotein lipase gene and their association with coronary artery disease in the Saudi population.

Authors:  Abdulaziz A Al-Jafari; Mohamed S Daoud; Abdulelah F Mobeirek; Mohammad S Al Anazi
Journal:  Int J Mol Sci       Date:  2012-06-18       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.